Skip to Content
Author: The BCW

Leave a Comment

Regeneron Antibody Cocktail Proved Effective Against COVID-19

More good news from BCW member Regeneron Pharmaceuticals which this week released a new analysis of data showing that its monoclonal antibody cocktail known as REGEN-COV is effective against Covid-19 infection.

Positive results from a Phase 3 trial jointly run with the National Institute of Allergy and Infectious Diseases showed that the drug reduces by 81.6% the risk of being infected by the Covid-19 virus, SARS-CoV-2. The data are from an ongoing clinical trial in which a group of participants received a 1,200-milligram dose of the drug in four injections administered under the skin.

The clinical trial involved 1,683 people who were tested to be sure they were not infected with Covid and did not have antibodies for the virus. Participants in the trial received either the Regeneron drug or a placebo. It was a double-blind study that initially kept secret the identities of participants who received the monoclonal antibodies and those who did not.

“Today’s new data demonstrate how a single dose of REGEN-COV can help protect people from Covid-19 for many months after administration,” said Myron S. Cohen, a doctor who leads the monoclonal antibody efforts for the Covid Prevention Network, which is sponsored by the National Institutes of Health.

George D. Yancopoulos, President and Chief Scientific Officer at Regeneron, said, “These data add to the increasing body of evidence supporting use of REGEN-COV to prevent Covid-19 in uninfected individuals, which may be especially useful for the many immunocompromised people who do not respond adequately to vaccines. With infections still occurring despite widespread vaccination, the immunocompromised face an ongoing risk of encountering the virus during their daily lives.”

Yancopoulos and Regeneron CEO Leonard Schleifer were awarded the BCW’s 2021 Global Leadership Laureate at last month’s Annual Dinner for their innovation, their development of the REGEN-COV therapy for post-exposure prevention of Covid-19, and for the company’s multi-billion-dollar investments in Westchester County.

Similar News Items

The Business Council of Westchester released its 2024 Legislative Agenda and called on state lawmakers to embrace policies that support a sustainable economy and job creation. The BCW produces the Annual Legislative Agenda each year for federal, state and local representatives on behalf of the business community. Among the recommendations in its 44-page report, the […]

Read Article

The Business Council of Westchester is among 43 business organizations representing tens of thousands of businesses of all sectors and sizes across New York urging the Senate and Assembly to allocate funding in the Fiscal Year 2025 budget to address the unemployment insurance debt; as well as support the Governor’s proposals to sunset the state’s […]

Read Article

Congratulations to the Burn Center at Westchester Medical Center on being verified by the American Burn Association (ABA) as an Adult and Pediatric Burn Center. The verification was made after a rigorous and thorough review of Westchester Medical Center’s burn care program. With this verification, BCW Member Westchester Medical Center is now home to the […]

Read Article

Become A Member

Join the county’s largest and most influential business organization today.

The Business Council of Westchester is committed to helping businesses market, learn, advocate, and grow. Over 80 events and programs are offered every year, giving our members ample opportunity to connect and meet with businesses representatives in the Westchester community and beyond.
Back to top